PARSIPPANY, N.J.--(BUSINESS WIRE)--DSP Clinical Research (DSP) has identified five errors pharmaceutical, biotech and medical device companies make when selecting a CRO to conduct a clinical study. DSP is a full service CRO that uses innovative approaches to successfully manage Phase I-IV clinical studies. In identifying the five errors, DSP Executive Director of West Coast Operations Brenda Reese, RN, explained, “When a small to mid-size sponsor chooses a CRO, the decision should be based on finding substance vs. style and facts vs. perception."
